A major caveat is that most studies that interrogate the link between E6* and p53 were performed on cell lines originating from cervical cancer or other non-HPV related cancers (119*), while only one study used an overexpression approach in a HPV-negative OPSCC cell line that harbors p53 mutations (125*). This evidence concerns the gene TP53 and cervical carcinoma.